2026-10-06
Global Collaboration Between CSL and Alentis to Develop and Commercialize Lixudebart for Treating Rare Kidney and Liver Diseases
CSL and Alentis have announced a global partnership to collaborate on the development and commercialization of Lixudebart, a treatment for...